EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis

J Barney Bryson iD, Alexandra Kourgiantaki, Dai Jiang, Andreas Demosthenous, Linda Greensmith iD

eLife · 2024

DOI: 10.7554/elife.88250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von J Barney Bryson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Motor Neurone Disease Association, Medical Research Council, UCLH Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breakdown of neuromuscular junctions (NMJs) is an early pathological hallmark of amyotrophic lateral sclerosis (ALS) that blocks neuromuscular transmission, leading to muscle weakness, paralysis and, ultimately, premature death. Currently, no therapies exist that can prevent progressive motor neuron degeneration, muscle denervation, or paralysis in ALS. Here, we report important advances in the development of an optogenetic, neural replacement strategy that can effectively restore innervation of severely affected skeletal muscles in the aggressive SOD1 G93A mouse model of ALS, thus providing an interface to selectively control the function of targeted muscles using optical stimulation. We also identify a specific approach to confer complete survival of allogeneic replacement motor neurons. Furthermore, we demonstrate that an optical stimulation training paradigm can prevent atrophy of reinnervated muscle fibers and results in a tenfold increase in optically evoked contractile force. Together, these advances pave the way for an assistive therapy that could benefit all ALS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisAnimalsMiceHumansOptogeneticsMuscle, SkeletalParalysisCell- and Tissue-Based TherapyDisease Models, Animal

Stichwörter der Autor:innen

ALSAmyotrophic Lateral Sclerosiscell transplantmotor neuronsmouseoptogeneticsparalysisregenerative medicinestem cells

Autor:innen und Institutionen

  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
  • UCL Queen Square Motor Neuron Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
  • Department of Electronic and Electrical Engineering, University College London, London, United Kingdom.

ORCID-Profile: J Barney Bryson, Linda Greensmith

Förderung

  • Motor Neurone Disease Association
  • Medical Research Council
  • UCLH Biomedical Research Centre
  • Rosetrees Trust
  • Richard Stravitz Foundation
  • Thierry Latran Foundation
  • Brain Research UK

Zitieren

APA

Bryson, J. B., Kourgiantaki, A., Jiang, D., Demosthenous, A., & Greensmith, L. (2024). An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis. eLife. https://doi.org/10.7554/elife.88250

Vancouver

Bryson JB, Kourgiantaki A, Jiang D, Demosthenous A, Greensmith L. An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis. eLife. 2024. doi:10.7554/elife.88250

BibTeX
@article{Bryson2024,
  author = {Bryson, J Barney and Kourgiantaki, Alexandra and Jiang, Dai and Demosthenous, Andreas and Greensmith, Linda},
  title = {An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.88250}
}
Kostenlos starten →